Obesity-related alterations in striatal dopamine D2 receptor signaling (Wang et al., 2001; Klein et al., 2007; Sevgi et al., 2015) or dopaminergic tone (Horstmann et al., 2015a) have been suggested to contribute to this. The gene discussed is DRD2; the disease is obesity due to melanocortin 4 receptor deficiency.